Bromantane
Russian actoprotectant adamantane; mild dopaminergic stimulant approved for asthenia.
Scientific Overview
Bromantane (Ladasten) is an adamantane-derived 'actoprotector' developed in the USSR and approved in Russia for asthenic disorders. It increases dopamine synthesis via tyrosine-hydroxylase upregulation and is on the WADA prohibited list. It is not a peptide but is grouped with nootropics in many libraries.
Key Research Benefits
- ✓Anti-fatigue without classical stimulant comedown
- ✓Mood elevation
- ✓Mild dopaminergic stim
Potential Side Effects
Research Protocols
Common DosagesAsthenia (Russia)
“Morning dose; courses of 2-4 weeks”
Dose Calculator
🧮 Peptide Reconstitution Calculator
Total amount of peptide in the vial.
Volume of water used to mix.
Draw to this mark
or 20.00 mL on a U-100 syringe
Explore Bromantane
Where to source
Vendors with public COAs that stock this category. Affiliate links are disclosed.
- Limitless Life NootropicsFL-based research-peptide supplier with Janoshik third-party COAs and a public affiliate program at ~20%.COA: JanoshikAffiliate disclosed
- SwissChems60+ peptide catalog with Janoshik COAs; weekly affiliate payouts.COA: JanoshikAffiliate disclosed
- Amino ClubEU/US-facing vendor with a 20% first-order / 10% recurring affiliate model.COA: Third-partyAffiliate disclosed
Bromantane by goal
Read Bromantane's profile filtered through specific research goals.
Molecular Profile
Quick Reference
- Status
- Research Compound
- Category
- Cognitive
- Common Dosage
- 50-100 mg
- Daily, oral
Strictly for research purposes. Not for human consumption.
Related tools
Medical Disclaimer
Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.